Seattle Genetics Announces Unanimous Recommendations from FDA Advisory Committee - SEAGEN INC COM (NASDAQ:SGEN)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that the Oncologic DrugsAdvisory Committee to the U.S. Food and Drug Administration voted10-0 to recommend that the FDA grant accelerated approval of ADCETRIS for the treatment of patients with Hodgkin lymphoma whorelapse after autologous stem cell transplant. In addition, ODAC voted10-0 to recommend that the FDA grant accelerated approval of ADCETRIS for thetreatment of patients with relapsed or refractory systemic anaplastic largecell lymphoma. The FDA is expected to act on the two Biologics LicenseApplications for ADCETRIS by August 30, 2011 under the PrescriptionDrug User Fee Act. ADCETRIS is an antibody-drug conjugate directed to CD30, a defining marker of Hodgkin lymphoma and ALCL.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!